APA (7th ed.) Citation

Dougan, M., Nguyen, L. H., Buchbinder, E. I., & Lazarus, H. M. (2024). Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer. Cancers, 16(3), 501. https://doi.org/10.3390/cancers16030501

Chicago Style (17th ed.) Citation

Dougan, Michael, Long H. Nguyen, Elizabeth I. Buchbinder, and Hillard M. Lazarus. "Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer." Cancers 16, no. 3 (2024): 501. https://doi.org/10.3390/cancers16030501.

MLA (9th ed.) Citation

Dougan, Michael, et al. "Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer." Cancers, vol. 16, no. 3, 2024, p. 501, https://doi.org/10.3390/cancers16030501.